Hormone drug shows promise for common fatty liver disease
NCT ID NCT03375788
Summary
This study tested whether a drug called tesamorelin could help people with obesity and nonalcoholic fatty liver disease (NAFLD). It involved 51 adults and aimed to see if the treatment could reduce harmful fat and inflammation in the liver. The drug works by boosting a natural hormone that regulates metabolism, which is often low in people with obesity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.